oncology
1,857 projects
breast cancer168leukemia137skin cancer106prostate cancer99colorectal cancer78lung cancer67pancreatic cancer42liver cancer37cervical cancer10bladder cancer10head and neck cancer7
H2020Individual fellowship2021–2023Italy
CONTACT · Cancer biOengineered Novel microTissues unrAveling Cancer plasTicity
H2020Individual fellowship2021–2023Germany
MECHANO FIBROSIS · Regulation of mechanotransduction through motor-molecules activation of focal adhesion kinase in progressive fibrosis
2 partners · 2 countries
H2020Individual fellowship2021–2024France
MITHAML · Exploring the role of Metabolic IntraTumoral Heterogeneity in drug resistance of Acute Myeloid Leukemia in vivo
2 partners · 2 countries
H2020Individual fellowship2021–2023Spain
SENAGE · Senescence as a key factor in leukemogenesis and bone marrow homeostasis in aging
H2020Individual fellowship2021–2024Germany
Tumour T cells · The fate and therapeutic potential of human neoantigen-specific T cells
H2020Individual fellowship2021–2023Germany
TFNup · Molecular, Structural, and Functional Studies of Leukemia-Associated Transcription Factor-Nucleoporin Fusion Proteins
H2020Individual fellowship2021–2023Denmark
EPiCC · Delineating epigenome regulators as functional survival dependencies in intrahepatic cholangiocarcinoma.
H2020Individual fellowship2021–2023Luxembourg
MEGAKINE · Megakines - novel tools for structural insight into receptor:chemokine complexes
H2020Individual fellowship2021–2022Portugal
OncoResist · Genetic and epigenetic resistance to oncogenic transformation of an epithelium
H2020Individual fellowship2021–2024Ireland
OvCaPreMed · OvCa for Precision Medicine: Personalized Ovarian Cancer Treatment using High-Throughput and Microfluidic Drug Screening.
2 partners · 2 countries
H2020Individual fellowship2021–2022United Kingdom
SCISSORS · Single cell profiling of breast tumors and the residing immune cells leveraged by integration with multi-dimensional molecular data from thousands of tumors
H2020Individual fellowship2021–2023Germany
SCEPTRE · Single Cell EPigenomic, Transcriptomic, and structural Rearrangement profiling to investigate Evolution in prostate cancer
H2020Individual fellowship2021–2023Spain
TARGETOF · Mass cytometry nanotools for intracellular target engagement. Towards precision medicine.
H2020Individual fellowship2021–2024United Kingdom
COSMOS · The Conformation Of S-phase chroMOSomes
2 partners · 2 countries
H2020Individual fellowship2021–2023Switzerland
miRanDa · microRNA assay system based on self-assembled nanoscale DNA origami arrays
H2020Individual fellowship2021–2024United Kingdom
GLoopID · Mechanisms underlying regulation and removal of G-quadruplex/R-loop transcription-replication conflicts
H2020Individual fellowship2021–2023France
MANTARGET · Super resolution imaging of nanoPMOs for cancer drug delivery
H2020Individual fellowship2021–2022Finland
TARNEPC · Targeting treatment-induced neuroendocrine prostate cancer
H2020Individual fellowship2021–2023Spain
NANOCRISPR · NANODELIVERY OF SPECIFIC GENOME ENGINEERING TOOLS AS A NOVEL THERAPEUTIC APPROACH FOR AGGRESSIVE PROSTATE CANCERS
H2020Individual fellowship2021–2023Spain
STIMULATE · STING signalling modulation via the Electron Transport Chain
H2020Individual fellowship2021–2023Switzerland
GlioTarget · Inflaming the microenvironment of glioblastoma tumors by ADAR1 inhibition: a two-hit approach for the treatment of brain cancer.
H2020Doctoral network2020–2024Italy
DIRNANO · Directing the immune response through designed nanomaterials
12 partners · 8 countries
H2020Doctoral network2020–2024Netherlands
VAGABOND · Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students
12 partners · 8 countries
H2020Doctoral network2020–2024Netherlands
HYPERBOOST · Creation of advanced cancer treatment planning to boost the effect of Radiotherapy by combining with hyperthermia, heating the tumor.
11 partners · 6 countries